Basilea Pharmaceutica AG Cash Flow Quality Index
Basilea Pharmaceutica AG cash flow quality index. Basilea Pharmaceutica AG (BSLN) has a Cash Flow Quality Index of 1.60x as of December 2025. Operating cash flow of CHF39.03 Million exceeds net income of CHF24.44 Million, indicating high earnings quality where cash backs reported profits. See financial agility of Basilea Pharmaceutica AG to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Basilea Pharmaceutica AG (2010–2025)
Cash flow quality index of Basilea Pharmaceutica AG from 2010 to 2025. Historical Cash Flow Quality Index for Basilea Pharmaceutica AG across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Basilea Pharmaceutica AG to assess how comfortably operating cash covers total debt obligations.
Basilea Pharmaceutica AG Cash Flow Quality Index by Year (2010–2025)
Basilea Pharmaceutica AG cash flow quality index by year from 2010 to 2025. Year-by-year earnings quality comparison for Basilea Pharmaceutica AG. For the full cash flow conversion analysis, see BSLN cash flow conversion.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.54x | CHF62.09 Million | CHF40.24 Million | ▲ +61.0% |
| 2024 | 0.96x | CHF74.36 Million | CHF77.59 Million | ▼ -29.7% |
| 2023 | 1.36x | CHF14.24 Million | CHF10.45 Million | ▲ +134.6% |
| 2022 | 0.58x | CHF7.06 Million | CHF12.15 Million | ▼ -41.4% |
| 2010 | 0.99x | CHF106.64 Million | CHF107.56 Million | — |